SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors rally around the company's recent US patent grant and the upcoming PDUFA date for its ADHD drug, CTx-1301. The community is heavily discussing the stock's low float potential and the likelihood of significant price movement as management pushes toward commercialization.

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena &gt; Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

CockCardano ($COCK) is surging in social sentiment as the community highlights its integration with real-world business revenue from Cocky Wings LLC to fuel token buybacks. Investors are rallying behind the project's unique mix of memecoin culture and tangible utility, frequently citing the strength of its community, staking rewards in the 'Arena,' and upcoming expansions as catalysts for long-term growth.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investor optimism surges ahead of its upcoming earnings report, with community sentiment fueled by major analyst price target upgrades and a structural memory shortage driving demand. Traders are actively discussing the stock's resilient momentum, its potential for a new all-time high, and its critical role in the broader AI infrastructure buildout.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is experiencing significant retail and institutional interest as investors position themselves ahead of the imminent registrational Phase 3 REGAL trial data for its AML treatment, GPS. The community is actively debating the trial's timeline and the high stakes of this binary catalyst, with many expressing optimism about a potential breakthrough or buyout while others express caution regarding the stock's recent volatility and the risks associated with the narrow window for clinical success.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trading in a volatile environment as investors closely monitor reports of military strikes on Iranian infrastructure and the resulting threat to global shipping through the Strait of Hormuz. The community is heavily focused on the potential for a sustained supply shock, debating the impact of increased energy costs on the broader economy while tracking conflicting reports regarding whether major shipping routes remain open.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood Markets is currently trending due to its high correlation with Bitcoin and intense investor debate over its long-term valuation following recent monthly performance data. Community sentiment remains deeply divided, with some traders highlighting the stock as oversold and an institutional favorite, while others express frustration over its volatile price action and frequent decoupling from crypto-market rallies.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

The Pepe community is actively debating the coin's potential for a major reversal, with many holders focusing on the "three frogs" narrative alongside $HOPPY and $FEFE. While sentiment remains polarized between those calling for a breakdown and those advocating for accumulation during this period of market volatility, the ongoing discourse centers on timing the next leg up and whether the meme sector will benefit from broader shifts in the cryptocurrency landscape.

Sui is an innovative layer-1 blockchain platform crafted to meet the demands of global adoption, providing a secure, robust, and scalable development environment. Rooted in a unique object-centric data model and fortified by the trusted Move programming language, Sui is engineered to tackle the inefficiencies found in current blockchain frameworks.  In addition to its solid technical underpinnings, Sui places a strong emphasis on user experience, aiming to remove common barriers encountered in blockchain interactions. Through groundbreaking features such as zkLogin, sponsored transactions, and programmable transaction blocks, Sui sets a new standard for user accessibility and friendliness within Web3 applications.  Unique elements of Sui Sui’s innovative architecture ensures swift transactions with stable fees and high throughput through horizontal scaling. Its object-oriented design offers deep composability for developers, enabling tailored object types with network-wide compatibility. This revolutionizes asset and protocol collaboration, fostering product innovation.  The platform's object-oriented approach dramatically improves transaction processing, enabling parallel execution and faster completion times. Additionally, unique consensus requirements expedite transaction finalization while maintaining stability. Sui prioritizes overcoming Web3 adoption barriers, offering native tools like zkLogin and sponsored transactions for wallet onboarding and fee management.  Move integration into Sui's data model combines innovation with security, mitigating common exploits found in smart contract languages. This empowers developers and users with a secure and intuitive platform, accelerating the evolution of Web3 applications.  About the Sui token The SUI token serves four primary functions within the Sui ecosystem: Proof-of-stake participation - Sui implements a delegated proof-of-stake mechanism, rewarding honest behavior by validators and SUI token holders who stake with them. Gas fee payments - SUI tokens cover gas fees for executing transactions and storing data onchain. Application utility - SUI is a versatile asset, integral to various applications within Sui’s ecosystem, including decentralized exchanges, lending platforms, gaming, and more. Governance - The SUI token empowers holders to participate in on-chain voting on significant matters like protocol upgrades and platform changes, shaping the future of Sui.  Additionally, the Sui storage fund ensures fair compensation for validators by distributing stake rewards over time and covering storage costs for previously stored on-chain data. This tokenomic strategy promotes indefinite data storage while maintaining fair compensation for validators, fostering long-term sustainability.

SUI is experiencing heightened market activity as traders react to positive ecosystem developments, including anticipation around potential institutional investment vehicles and its performance relative to other layer-one blockchains. The community is actively debating its growth prospects, with many focused on aggressive accumulation strategies while others remain focused on technical resistance levels during this volatile phase.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is currently facing downward pressure due to a reported delay in its 'Avocado' AI model and broader concerns regarding the massive capital expenditures required to sustain AI infrastructure. While community sentiment remains divided between those viewing the pullback as a buying opportunity and others skeptical of the company's efficiency, traders are focused on key support levels and the potential impact of cost-cutting measures on future margins.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating significant community excitement as investors anticipate major catalysts including upcoming trial readouts and potential commercial milestones following recent Japan regulatory progress. While the stock navigates a volatile biotech landscape, bulls are actively accumulating shares, citing a strong cash runway and bullish technical signals that suggest a potential breakout to higher price levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DAWN announced it was being acquired by Servier this morning for a market cap of $2.5B. The attachment compares DAWN&#39;s M&amp;A exit enterprise valuation &amp; analyst consensus revenue estimates to 8 commercial-stage peers that exited at roughly the same valuation. 
 
Our estimated enterprise value takes DAWN&#39;s $441MM 12/31/25 net cash &amp; assumes a net $100MM outflow for Mersana (net of Mersana cash acquired). 
 
We will update the attachment with DAWN mgmt/BOD forecast when available (when they file their 14A or 14D9 with the SEC in roughly 1 month). 
 
FWIW DAWN&#39;s M&amp;A multiples appear, more or less, consistent with all peers at 4.1X Year 4 &amp; 0.35X cumulative 10-year revenues. 
 
This is not investment advice. However, the DAWN exit may shine a spotlight on other oncology focused M&amp;A candidates including $SNDX $IOVA $URGN  
 
$XBI

Daniel Jenkins

Sood

kledru

Peter Odinson

Nadia Laurent

hottehueh

Natalie N

Rajesh

Bert Igermann

Alan Purdie

Daniel Zedek

Atanas

Georgeson

StockTwits Web

Day One Biopharmaceuticals Inc

Syndax Pharmaceuticals Inc

Iovance Biotherapeutics Inc

UroGen Pharma Ltd

SPDR S&P Biotech ETF

 announced it was being acquired by Servier this morning for a market cap of $2.5B. The attachment compares DAWN's M&A exit enterprise valuation & analyst consensus revenue estimates to 8 commercial-stage peers that exited at roughly the same valuation. 
 
Our estimated enterprise value takes DAWN's $441MM 12/31/25 net cash & assumes a net $100MM outflow for Mersana (net of Mersana cash acquired). 
 
We will update the attachment with DAWN mgmt/BOD forecast when available (when they file their 14A or 14D9 with the SEC in roughly 1 month). 
 
FWIW DAWN's M&A multiples appear, more or less, consistent with all peers at 4.1X Year 4 & 0.35X cumulative 10-year revenues. 
 
This is not investment advice. However, the DAWN exit may shine a spotlight on other oncology focused M&A candidates including 

iShares Biotechnology ETF

Incyte Corp.

NASDAQ Biotechnology

Night Owl Biotech Research

@Night_Owl_Biotech can&#39;t thank you enough! Your analysis is always so good, loaded with facts.. really appreciate you and your team!

Guys - follow this poster to get good analysis and to make money !

VitalBull

StockTwits For Android 

 can't thank you enough! Your analysis is always so good, loaded with facts.. really appreciate you and your team!

Guys - follow this poster to get good analysis and to make money !

TG Therapeutics Inc

@Night_Owl_Biotech Great work! Very much appreciated.

Teva- Pharmaceutical Industries Ltd. - ADR

Campbell Soup Co.

Pfizer Inc

Viking Therapeutics Inc

Carvana Co.

Legend Biotech

Central Plains Bancshares Inc

Zac Allen

@Night_Owl_Biotech well done! Congratulations! I’m so happy for you and I appreciate all of your analysis with these biotech stocks.

StockTwits for iOS

 well done! Congratulations! I’m so happy for you and I appreciate all of your analysis with these biotech stocks.

Adicet Bio Inc

Geron Corp.

Rigel Pharmaceuticals

Sutro Biopharma Inc

@Night_Owl_Biotech what are your views on $URGN BO possiblity as you highlighted in your thread. Where can I find your analysis on this stock and BO possibility, reasoning and price?
Thank you!

 BO possiblity as you highlighted in your thread. Where can I find your analysis on this stock and BO possibility, reasoning and price?
Thank you!

@flanker30  
 
Attached is a comparison of URGN 10-year analyst consensus revenue estimates v. 13 URGN peers that exited via M&amp;A. Note most URGN peers were acquired for 0.30 to 0.39X cumulative 10-year revenue projections (as prepared by the acquiree mgmt/BOD). URGN&#39;s gross margins are, more or less, consistent with all 13. 
 
Note analysts forecast URGN to generate $8.386B in cumulative revenues over the next 10-year? If URGN analyst estimates are credible AND if Jelmyto &amp; Zusduri merit peer M&amp;A multiples (2 HUGE IFs) then URGN should be worth at least $2.1B in enterprise value in a M&amp;A exit (subtract debt to get to a market cap). 
 
We&#39;ll prepare an updated URGN cap table once URGN files their 10K. Very back of the envelope, URGN has 60MM fully diluted shares so this would be $35/share. 
 
Just remember URGN has patent life issues with both drugs. UGN-103 &amp; 104 should work out but the uncertainty could manifest in lower revenue multiples. 
 
As always, this is not investment advice.

  
 
Attached is a comparison of URGN 10-year analyst consensus revenue estimates v. 13 URGN peers that exited via M&A. Note most URGN peers were acquired for 0.30 to 0.39X cumulative 10-year revenue projections (as prepared by the acquiree mgmt/BOD). URGN's gross margins are, more or less, consistent with all 13. 
 
Note analysts forecast URGN to generate $8.386B in cumulative revenues over the next 10-year? If URGN analyst estimates are credible AND if Jelmyto & Zusduri merit peer M&A multiples (2 HUGE IFs) then URGN should be worth at least $2.1B in enterprise value in a M&A exit (subtract debt to get to a market cap). 
 
We'll prepare an updated URGN cap table once URGN files their 10K. Very back of the envelope, URGN has 60MM fully diluted shares so this would be $35/share. 
 
Just remember URGN has patent life issues with both drugs. UGN-103 & 104 should work out but the uncertainty could manifest in lower revenue multiples. 
 
As always, this is not investment advice.

@Night_Owl_Biotech Huge thanks for sharing the details and your analysis!!

URGN looks like one of your top contenders for BO in near future, apart from SNDX, IOVA.
Any other stock(s) you recommend? Thanks again, have a good weekend..

 Huge thanks for sharing the details and your analysis!!

URGN looks like one of your top contenders for BO in near future, apart from SNDX, IOVA.
Any other stock(s) you recommend? Thanks again, have a good weekend..

@flanker30  
 
Of course. I fu(king love this stuff! It&#39;s also good to make a few dollars for a change :) 
 
Should history repeat itself, we should have 2 more M&amp;A exits in this peer group by May 31. My God I wish I knew who. Legend holds their CC Tuesday. They are definitely a candidate shortly thereafter. 
 
FWIW I am thinking it will not be SNDX, though I won&#39;t sell 1 SNDX share I own. SNDX has to be waiting for something or they would have sold out at JP Morgan. At this point I suspect it is the IDF data but it&#39;s probably something for which the public is unaware. 
 
ZYME is definitely another compelling candidate, especially if JAZZ wanted DAWN &amp; lost out. 
 
More to come.

  
 
Of course. I fu(king love this stuff! It's also good to make a few dollars for a change :) 
 
Should history repeat itself, we should have 2 more M&A exits in this peer group by May 31. My God I wish I knew who. Legend holds their CC Tuesday. They are definitely a candidate shortly thereafter. 
 
FWIW I am thinking it will not be SNDX, though I won't sell 1 SNDX share I own. SNDX has to be waiting for something or they would have sold out at JP Morgan. At this point I suspect it is the IDF data but it's probably something for which the public is unaware. 
 
ZYME is definitely another compelling candidate, especially if JAZZ wanted DAWN & lost out. 
 
More to come.